FilingSEC EDGAR6-K
Nasus Pharma to Hold Annual and Special General Meeting on October 8
· SEC accepted
StageMeeting Notice
Filing content
Nasus Pharma will hold an Annual and Special General Meeting of Shareholders on October 8, 2026, to vote on matters including CEO compensation and auditor reappointment.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…